93 related articles for article (PubMed ID: 35668920)
1. Molecular docking of ethanol extracts of katuk leaf (
Makati AC; Ananda AN; Putri JA; Amellia SF; Setiawan B
S Afr J Bot; 2022 Sep; 149():1-5. PubMed ID: 35668920
[TBL] [Abstract][Full Text] [Related]
2. Determination of the Major Component of Water Fraction of Katuk (
Mustarichie R; Salsabila T; Iskandar Y
J Pharm Bioallied Sci; 2019 Dec; 11(Suppl 4):S611-S618. PubMed ID: 32148372
[TBL] [Abstract][Full Text] [Related]
3. Repurposing FDA-approved drugs against multiple proteins of SARS-CoV-2: An
Akinlalu AO; Chamundi A; Yakumbur DT; Afolayan FID; Duru IA; Arowosegbe MA; Enejoh OA
Sci Afr; 2021 Sep; 13():e00845. PubMed ID: 34308004
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 liver and gastroenterology findings: An
Peiter GC; de Souza CBT; de Oliveira LM; Pagliarin LG; Dos Anjos VNF; da Silva FAF; de Melo FF; Teixeira KN
World J Hepatol; 2022 Jun; 14(6):1131-1141. PubMed ID: 35978663
[TBL] [Abstract][Full Text] [Related]
5. In silico discovery of 3 novel quercetin derivatives against papain-like protease, spike protein, and 3C-like protease of SARS-CoV-2.
Bhattacharya K; Bordoloi R; Chanu NR; Kalita R; Sahariah BJ; Bhattacharjee A
J Genet Eng Biotechnol; 2022 Mar; 20(1):43. PubMed ID: 35262828
[TBL] [Abstract][Full Text] [Related]
6. In silico docking analysis revealed the potential of phytochemicals present in
Hiremath S; Kumar HDV; Nandan M; Mantesh M; Shankarappa KS; Venkataravanappa V; Basha CRJ; Reddy CNL
3 Biotech; 2021 Feb; 11(2):44. PubMed ID: 33457171
[TBL] [Abstract][Full Text] [Related]
7. Flavonoid glycosides and their putative human metabolites as potential inhibitors of the SARS-CoV-2 main protease (Mpro) and RNA-dependent RNA polymerase (RdRp).
da Silva FMA; da Silva KPA; de Oliveira LPM; Costa EV; Koolen HH; Pinheiro MLB; de Souza AQL; de Souza ADL
Mem Inst Oswaldo Cruz; 2020; 115():e200207. PubMed ID: 33027419
[TBL] [Abstract][Full Text] [Related]
8. Computational Evidences of Phytochemical Mediated Disruption of PLpro Driven Replication of SARS-CoV-2: A Therapeutic Approach against COVID-19.
Balkrishna A; Mittal R; Arya V
Curr Pharm Biotechnol; 2021; 22(10):1350-1359. PubMed ID: 33176643
[TBL] [Abstract][Full Text] [Related]
9. Effects of dietary katuk (Sauropus androgynus L. Merr.) on growth, non-specific immune and diseases resistance against Vibrio alginolyticus infection in grouper Epinephelus coioides.
Samad AP; Santoso U; Lee MC; Nan FH
Fish Shellfish Immunol; 2014 Feb; 36(2):582-9. PubMed ID: 24296304
[TBL] [Abstract][Full Text] [Related]
10. In silico identification of compounds from
Duru CE; Duru IA; Adegboyega AE
Bull Natl Res Cent; 2021; 45(1):57. PubMed ID: 33727782
[TBL] [Abstract][Full Text] [Related]
11. Potential combination therapy using twenty phytochemicals from twenty plants to prevent SARS- CoV-2 infection: An in silico Approach.
Dey D; Dey N; Ghosh S; Chandrasekaran N; Mukherjee A; Thomas J
Virusdisease; 2021 Mar; 32(1):108-116. PubMed ID: 33842675
[TBL] [Abstract][Full Text] [Related]
12. Metabologenomics approach to the discovery of novel compounds from
Melinda YN; Widada J; Wahyuningsih TD; Febriansah R; Damayanti E; Mustofa M
Heliyon; 2021 Nov; 7(11):e08308. PubMed ID: 34746476
[TBL] [Abstract][Full Text] [Related]
13. A multi-targeted approach to identify potential flavonoids against three targets in the SARS-CoV-2 life cycle.
Kumar S; Paul P; Yadav P; Kaul R; Maitra SS; Jha SK; Chaari A
Comput Biol Med; 2022 Mar; 142():105231. PubMed ID: 35032740
[TBL] [Abstract][Full Text] [Related]
14.
Pagliarin LG; de Oliveira LM; Dos Anjos VNF; de Souza CBT; Peiter GC; Façanha Wendel C; Dillmann Groto A; Freire de Melo F; Teixeira KN
World J Biol Chem; 2023 Jul; 14(4):72-83. PubMed ID: 37547340
[TBL] [Abstract][Full Text] [Related]
15. Targeting the vital non-structural proteins (NSP12, NSP7, NSP8 and NSP3) from SARS-CoV-2 and inhibition of RNA polymerase by natural bioactive compound naringenin as a promising drug candidate against COVID-19.
Aleebrahim-Dehkordi E; Ghoshouni H; Koochaki P; Esmaili-Dehkordi M; Aleebrahim E; Chichagi F; Jafari A; Hanaei S; Heidari-Soureshjani E; Rezaei N
J Mol Struct; 2023 Sep; 1287():135642. PubMed ID: 37131962
[TBL] [Abstract][Full Text] [Related]
16. Screening marine algae metabolites as high-affinity inhibitors of SARS-CoV-2 main protease (3CLpro): an in silico analysis to identify novel drug candidates to combat COVID-19 pandemic.
Muteeb G; Alshoaibi A; Aatif M; Rehman MT; Qayyum MZ
Appl Biol Chem; 2020; 63(1):79. PubMed ID: 33251389
[TBL] [Abstract][Full Text] [Related]
17.
Maurya AK; Mishra N
J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
[TBL] [Abstract][Full Text] [Related]
18. A molecular dynamics simulation study of the ACE2 receptor with screened natural inhibitors to identify novel drug candidate against COVID-19.
Srivastava N; Garg P; Srivastava P; Seth PK
PeerJ; 2021; 9():e11171. PubMed ID: 33981493
[TBL] [Abstract][Full Text] [Related]
19. Two conserved oligomer interfaces of NSP7 and NSP8 underpin the dynamic assembly of SARS-CoV-2 RdRP.
Biswal M; Diggs S; Xu D; Khudaverdyan N; Lu J; Fang J; Blaha G; Hai R; Song J
Nucleic Acids Res; 2021 Jun; 49(10):5956-5966. PubMed ID: 33999154
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
